116 related articles for article (PubMed ID: 9389601)
1. A neutral N-methyltransferase activity in the striatum determines the level of an endogenous MPP+-like neurotoxin, 1,2-dimethyl-6,7-dihydroxyisoquinolinium ion, in the substantia nigra of human brains.
Naoi M; Maruyama W; Matsubara K; Hashizume Y
Neurosci Lett; 1997 Oct; 235(1-2):81-4. PubMed ID: 9389601
[TBL] [Abstract][Full Text] [Related]
2. N-methyl(R)salsolinol and a neutral N-methyltransferase as pathogenic factors in Parkinson's disease.
Maruyama W; Strolin-Benedetti M; Naoi M
Neurobiology (Bp); 2000; 8(1):55-68. PubMed ID: 11008878
[TBL] [Abstract][Full Text] [Related]
3. A dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl(R)salsolinol, and its oxidation product, 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion, accumulate in the nigro-striatal system of the human brain.
Maruyama W; Sobue G; Matsubara K; Hashizume Y; Dostert P; Naoi M
Neurosci Lett; 1997 Feb; 223(1):61-4. PubMed ID: 9058423
[TBL] [Abstract][Full Text] [Related]
4. (R)salsolinol N-methyltransferase activity increases in parkinsonian lymphocytes.
Naoi M; Maruyama W; Nakao N; Ibi T; Sahashi K; Benedetti MS
Ann Neurol; 1998 Feb; 43(2):212-6. PubMed ID: 9485062
[TBL] [Abstract][Full Text] [Related]
5. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.
Naoi M; Maruyama W; Nagy GM
Neurotoxicology; 2004 Jan; 25(1-2):193-204. PubMed ID: 14697894
[TBL] [Abstract][Full Text] [Related]
6. Oxidation of N-methyl(R)salsolinol: involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines.
Naoi M; Maruyama W; Kasamatsu T; Dostert P
J Neural Transm Suppl; 1998; 52():125-38. PubMed ID: 9564615
[TBL] [Abstract][Full Text] [Related]
7. Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies.
Naoi M; Maruyama W; Dostert P; Hashizume Y; Nakahara D; Takahashi T; Ota M
Brain Res; 1996 Feb; 709(2):285-95. PubMed ID: 8833765
[TBL] [Abstract][Full Text] [Related]
8. Cell death of dopamine neurons in aging and Parkinson's disease.
Naoi M; Maruyama W
Mech Ageing Dev; 1999 Nov; 111(2-3):175-88. PubMed ID: 10656535
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopamine neurons.
Naoi M; Maruyama W; Akao Y; Zhang J; Parvez H
Toxicology; 2000 Nov; 153(1-3):123-41. PubMed ID: 11090952
[TBL] [Abstract][Full Text] [Related]
10. Increased beta-carboline 9N-methyltransferase activity in the frontal cortex in Parkinson's disease.
Gearhart DA; Collins MA; Lee JM; Neafsey EJ
Neurobiol Dis; 2000 Jun; 7(3):201-11. PubMed ID: 10860785
[TBL] [Abstract][Full Text] [Related]
11. Acetylcholinesterase in the substantia nigra and caudate-putamen of the rat: properties and localization in dopaminergic neurons.
Lehmann J; Fibiger HC
J Neurochem; 1978 Mar; 30(3):615-24. PubMed ID: 681936
[No Abstract] [Full Text] [Related]
12. Homospecific activity (activity per enzyme protein) of tyrosine hydroxylase increases in parkinsonian brain.
Mogi M; Harada M; Kiuchi K; Kojima K; Kondo T; Narabayashi H; Rausch D; Riederer P; Jellinger K; Nagatsu T
J Neural Transm; 1988; 72(1):77-82. PubMed ID: 2897999
[TBL] [Abstract][Full Text] [Related]
13. N-methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study.
Maruyama W; Nakahara D; Ota M; Takahashi T; Takahashi A; Nagatsu T; Naoi M
J Neurochem; 1992 Aug; 59(2):395-400. PubMed ID: 1629715
[TBL] [Abstract][Full Text] [Related]
14. [Pathogenesis of idiopathic Parkinson's disease].
Maruyama W
Nihon Ronen Igakkai Zasshi; 2001 Jul; 38(4):494-7. PubMed ID: 11523160
[TBL] [Abstract][Full Text] [Related]
15. Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease.
Naoi M; Maruyama W; Akao Y; Yi H
Neurotoxicol Teratol; 2002; 24(5):579-91. PubMed ID: 12200189
[TBL] [Abstract][Full Text] [Related]
16. Dopamine-derived 1-methyl-6,7-dihydroxyisoquinolines as hydroxyl radical promoters and scavengers in the rat brain: in vivo and in vitro studies.
Maruyama W; Dostert P; Naoi M
J Neurochem; 1995 Jun; 64(6):2635-43. PubMed ID: 7760044
[TBL] [Abstract][Full Text] [Related]
17. N-methyl-(R)salsolinol as a dopaminergic neurotoxin: from an animal model to an early marker of Parkinson's disease.
Naoi M; Maruyama W; Dostert P; Hashizume Y
J Neural Transm Suppl; 1997; 50():89-105. PubMed ID: 9120428
[TBL] [Abstract][Full Text] [Related]
18. N-methylated tetrahydroisoquinolines as dopaminergic neurotoxins.
Naoi M; Dostert P; Yoshida M; Nagatsu T
Adv Neurol; 1993; 60():212-7. PubMed ID: 8420137
[TBL] [Abstract][Full Text] [Related]
19. Topographic projections of substance P and GABA pathways in the striato- and pallido-nigral system: a biochemical and immunohistochemical study.
Jessell TM; Emson PC; Paxinos G; Cuello AC
Brain Res; 1978 Sep; 152(3):487-98. PubMed ID: 356929
[TBL] [Abstract][Full Text] [Related]
20. An endogenous dopaminergic neurotoxin, N-methyl-(R)-salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells.
Maruyama W; Naoi M; Kasamatsu T; Hashizume Y; Takahashi T; Kohda K; Dostert P
J Neurochem; 1997 Jul; 69(1):322-9. PubMed ID: 9202326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
